Cytodyn Inc (CYDY)

[C-20]

Monroe1- it’s a concept they don’t want to grasp. CyDy ‘s EINDS we’re successful in large part because we used 4 doses in many cases. The FDA saw this and realized it would have to approve Leronlimab if in fact a 4 dose trial was given. As we all know it wasn’t. That number of 62 that everyone keeps referring to as a small subset was achieved with only 2 doses let’s not forget that with 4 doses that 82% would have jumped even higher and across the board. If this drug didn’t work do you really think it would be the subject of this much attention. Longs keep fighting as I know you will this thing is certainly not over